OpenAI-Backed Red Queen Bio Raises $36M to Design Antiviral Antibodies
Biosecurity startup Red Queen Bio has raised $36 million in total funding to develop an AI platform that designs antibody therapies against existing and synthetic viral threats.
Archive
Biosecurity startup Red Queen Bio has raised $36 million in total funding to develop an AI platform that designs antibody therapies against existing and synthetic viral threats.
